4568.T: Daiichi Sankyo Company, Limited Stock Live Price Graph
About the company
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively involved in the research, development, manufacturing, importation, marketing, and distribution of a diverse array of medicinal products worldwide. Its extensive product lineup addresses numerous therapeutic areas. In oncology, key offerings include trastuzumab deruxtecan, an anti-HER2 antibody drug conjugate, alongside treatments like Gefitinib for malignant tumors, Bicalutamide for prostate cancer, and Tamoxifen, an anti-breast cancer agent. For pain management, the company provides mirogabalin and loxoprofen (an anti-inflammatory analgesic). Diabetes treatments feature teneligliptin/canagliflozin and teneligliptin, with colesevelam serving dual purposes for hypercholesterolemia and type 2 diabetes. Other notable prescription drugs include lacosamide (an anti-epileptic), prasugrel (an antiplatelet), denosumab (for osteoporosis and bone disorders), edoxaban (an anticoagulant), esomeprazole (for ulcer treatment), memantine (for Alzheimer's disease), and laninamivir (for influenza). The company also supplies olmesartan (an antihypertensive), levofloxacin (an antibacterial), pravastatin (for hypercholesterolemia), Silodosin (for dysuria), and ferric carboxymaltose/iron sucrose injections for anemia. Beyond prescription medications, Daiichi Sankyo markets popular consumer health brands such as Lulu (a combination cold remedy), Loxonin S (an antipyretic/anti-inflammatory painkiller), Transino (for melasma and skin improvement), Minon (skincare), and the oral care lines Breath Labo and Clean Dental. The company further contributes to public health with various vaccines, including adsorbed cell culture-derived influenza, influenza HA, measles-rubella combined, and mumps vaccines. Its operations also extend beyond human pharmaceuticals to include veterinary drugs, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and intermediates. Daiichi Sankyo is collaborating with Guardant Health on the development of Guardant360 CDx, a companion diagnostic for Enhertu, specifically for advanced metastatic non-small cell lung cancer. Founded in 1899, the company is headquartered in Tokyo, Japan.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $50 | $50 | 3.93% | - |
| - | $50 | $50 | 3.50% | - |
| - | $39 | $39 | 2.77% | - |
| - | $39 | $39 | 2.09% | - |
| - | $30 | $30 | 1.70% | - |
| - | $30 | $30 | 1.28% | - |
| - | $30 | $30 | 1.04% | - |
| - | $20 | $20 | 0.84% | - |
| - | $15 | $15 | 0.63% | - |
| - | $13.5 | $13.5 | 0.71% | - |
| - | $13.5 | $13.5 | 1.00% | - |
| - | $13.5 | $13.5 | 0.92% | - |
| - | $13.5 | $13.5 | 0.82% | - |
| - | $13.5 | $13.5 | 0.77% | - |
| - | $35 | $35 | 0.91% | - |
| - | $35 | $35 | 1.01% | - |
| - | $35 | $35 | 1.56% | - |
| - | $35 | $35 | 1.45% | - |
| - | $35 | $35 | 1.97% | - |
| - | $35 | $35 | 2.76% | - |
| - | $35 | $35 | 2.74% | - |
| - | $35 | $35 | 2.68% | - |
| - | $30 | $30 | 1.59% | - |
| - | $10 | $10 | 1.89% | - |
| - | $30 | $30 | 3.12% | - |
| - | $30 | $30 | 3.41% | - |
| - | $30 | $30 | 3.50% | - |
| - | $30 | $30 | 3.32% | - |
| - | $30 | $30 | 3.29% | - |
| - | $30 | $30 | 4.62% | - |
| - | $30 | $30 | 3.92% | - |
| - | $30 | $30 | 3.73% | - |
| - | $30 | $30 | 3.79% | - |
| - | $30 | $30 | 3.52% | - |
| - | $30 | $30 | 3.38% | - |
| - | $30 | $30 | 3.76% | - |
| - | $40 | $40 | 4.65% | - |
| - | $40 | $40 | 2.55% | - |
| - | $35 | $35 | 2.42% | - |
| - | $35 | $35 | 1.95% | - |
| - | $30 | $30 | 1.69% | - |
| - | $30 | $30 | 1.74% | - |
| - | $25 | $25 | 0.98% | - |
| - | $75 | $75 | 3.56% | - |
| - | $15 | $15 | 1.31% | - |
| - | $10 | $10 | 0.98% | - |
| - | $10 | $10 | 1.06% | - |
| - | $10 | $10 | 1.39% | - |
| - | $12.5 | $12.5 | 0.77% | - |
| - | $2.5 | $2.5 | 0.20% | - |
| - | $2.5 | $2.5 | 0.58% | - |
| - | $12.25 | $12.25 | 0.86% | - |
| - | $12.25 | $12.25 | 0.94% | - |
| - | $12.25 | $12.25 | 0.79% | - |
What Is 4568.T? Live 4568.T Prices and Analysis
4568.T is the stock symbol for a notable company listed on the Tokyo Stock Exchange, representing a significant player in its respective industry. Investors closely monitor this stock due to its economic importance and the potential for growth it offers. The performance of 4568.T can impact not only individual portfolios but also the broader market sentiment in Japan and beyond.
As a publicly traded entity, 4568.T is subject to market forces and investor sentiment, making it an essential component of many investment strategies. Understanding its price movements and underlying economic factors can help investors make informed decisions.
Market Context for 4568.T
The trading environment for 4568.T is influenced by various international factors, including global economic conditions, currency fluctuations, and geopolitical events. The stock is priced in Japanese yen, and its valuation can be affected by the strength of the yen against other currencies. Market volatility can also impact investor confidence, leading to rapid changes in stock prices.
Why Do 4568.T Prices Rise or Fall?
The price of 4568.T can fluctuate for a multitude of reasons, reflecting both external market conditions and internal company performance. Understanding these factors can provide insights into potential price movements.
- Company earnings reports and forecasts
- Changes in industry regulations
- Market sentiment and investor behavior
- Economic indicators such as GDP growth and unemployment rates
- Technological advancements or setbacks
- Competitive landscape and market share dynamics
- Geopolitical events affecting trade and investment
- Dividend announcements and changes in payout ratios
These factors can create a complex interplay that influences the stock's performance, making it crucial for investors to stay informed and analyze data effectively.
Why Is Live 4568.T Price Tracking Important?
Tracking the live price of 4568.T is essential for both active traders and long-term investors. Real-time data can provide insights into market trends and help investors make timely decisions.
- Helps in identifying entry and exit points
- Enables monitoring of market sentiment
- Facilitates better risk management strategies
- Enhances understanding of price volatility
- Supports informed decision-making based on real-time data
What Should You Consider When Trading / Investing in 4568.T?
Investing in 4568.T involves certain risks and considerations that investors should keep in mind. The stock market can be unpredictable, and various macroeconomic factors can influence stock performance.
- Assess the company's financial health through earnings reports and P/E ratios
- Be aware of market volatility and its potential impact on the stock price
- Consider broader economic indicators and their implications
- Stay updated on company news and industry trends
- Evaluate your risk tolerance and investment goals
What Can You Find on the Investvio 4568.T Page?
- Live price updates and historical data
- Interactive price charts for technical analysis
- Latest news and developments related to 4568.T
- Expert analysis and market forecasts
- Dividend information and company announcements
The Investvio page dedicated to 4568.T is an invaluable resource for investors looking to stay informed and make strategic decisions in their trading activities. By utilizing the information available, investors can enhance their understanding of the stock and its potential for growth.